Development of gene therapy for cystic fibrosis

Faculty members Michael Welsh, MD, a Howard Hughes Medical investigator, and Joseph Zabner, MD, used gene insertion techniques to successfully correct the defect in human cystic fibrosis (CF) cells in a laboratory culture. This was the nation's first, though temporary, application of gene therapy for CF.